CT Perfusion Predicts Treatment Response in Cancer Patients
By MedImaging International staff writers Posted on 03 Jul 2017 |
Image: Dr. Ting-Yim Lee demonstrates the CT perfusion technology (Photo courtesy of Western University).
The results of a multi-center feasibility study and clinical trial have shown how CT perfusion can be used to predict the treatment response of patients with advanced ovarian cancer.
Computed Tomography (CT) perfusion measures the volume and flow of blood to ovarian cancer tumors. This can provide an accurately prediction of treatment response and enable clinicians to improve treatment planning.
The trial included 120 enrolled patients, of which 76 patients, with a median age of 61 years from 19 centers were evaluated. The study was published online in the May 15, 2017, issue of the journal Clinical Cancer Research by scientists from Western University (London, ON, Canada) and Lawson Health Research Institute (London, ON, Canada).
According to the authors of the study, most ovarian cancer patients (60 to 85%) suffer from a relapse after initial treatment. This shows the importance of the new CT perfusion technique that enables clinicians to predict patients’ response to specific therapy, and improves treatment planning and patient selection.
One of the researchers, Ting-Yim Lee, professor at Western University and scientist at Lawson Health Research Institute, said, "CT perfusion is honing into the change in blood flow to the tumor before and after treatment. In this particular case we can see that blood flow tends to decrease in those who will survive longer without symptoms, whereas for those whose symptoms will recur within six months, we saw blood flow to the tumor increase after their treatment. Using this method we are able to see a change in the blood flow as early as four weeks after treatment. This means we don't have to wait months to determine whether symptoms will recur, we are able to tell whether the treatment is effective much sooner."
Related Links:
Western University
Lawson Health Research Institute
Computed Tomography (CT) perfusion measures the volume and flow of blood to ovarian cancer tumors. This can provide an accurately prediction of treatment response and enable clinicians to improve treatment planning.
The trial included 120 enrolled patients, of which 76 patients, with a median age of 61 years from 19 centers were evaluated. The study was published online in the May 15, 2017, issue of the journal Clinical Cancer Research by scientists from Western University (London, ON, Canada) and Lawson Health Research Institute (London, ON, Canada).
According to the authors of the study, most ovarian cancer patients (60 to 85%) suffer from a relapse after initial treatment. This shows the importance of the new CT perfusion technique that enables clinicians to predict patients’ response to specific therapy, and improves treatment planning and patient selection.
One of the researchers, Ting-Yim Lee, professor at Western University and scientist at Lawson Health Research Institute, said, "CT perfusion is honing into the change in blood flow to the tumor before and after treatment. In this particular case we can see that blood flow tends to decrease in those who will survive longer without symptoms, whereas for those whose symptoms will recur within six months, we saw blood flow to the tumor increase after their treatment. Using this method we are able to see a change in the blood flow as early as four weeks after treatment. This means we don't have to wait months to determine whether symptoms will recur, we are able to tell whether the treatment is effective much sooner."
Related Links:
Western University
Lawson Health Research Institute
Latest Radiography News
- Novel Breast Imaging System Proves As Effective As Mammography
- AI Assistance Improves Breast-Cancer Screening by Reducing False Positives
- AI Could Boost Clinical Adoption of Chest DDR
- 3D Mammography Almost Halves Breast Cancer Incidence between Two Screening Tests
- AI Model Predicts 5-Year Breast Cancer Risk from Mammograms
- Deep Learning Framework Detects Fractures in X-Ray Images With 99% Accuracy
- Direct AI-Based Medical X-Ray Imaging System a Paradigm-Shift from Conventional DR and CT
- Chest X-Ray AI Solution Automatically Identifies, Categorizes and Highlights Suspicious Areas
- AI Diagnoses Wrist Fractures As Well As Radiologists
- Annual Mammography Beginning At 40 Cuts Breast Cancer Mortality By 42%
- 3D Human GPS Powered By Light Paves Way for Radiation-Free Minimally-Invasive Surgery
- Novel AI Technology to Revolutionize Cancer Detection in Dense Breasts
- AI Solution Provides Radiologists with 'Second Pair' Of Eyes to Detect Breast Cancers
- AI Helps General Radiologists Achieve Specialist-Level Performance in Interpreting Mammograms
- Novel Imaging Technique Could Transform Breast Cancer Detection
- Computer Program Combines AI and Heat-Imaging Technology for Early Breast Cancer Detection